Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis - PubMed (original) (raw)
Multicenter Study
. 2017 Feb;66(2):278-284.
doi: 10.1136/gutjnl-2015-310630. Epub 2015 Nov 24.
S A Q Rana 2, N S S Atkinson 3, Y J van Herwaarden 4, B A J Bastiaansen 1, M E van Leerdam 5, S Sanduleanu 6, T M Bisseling 4, M C W Spaander 7, S K Clark 2, G A Meijer 8, N van Lelyveld 9, J J Koornstra 10, I D Nagtegaal 11, J E East 3, A Latchford 2, E Dekker 1; Dutch workgroup serrated polyps & polyposis (WASP)
Affiliations
- PMID: 26603485
- DOI: 10.1136/gutjnl-2015-310630
Free article
Multicenter Study
Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis
J E G IJspeert et al. Gut. 2017 Feb.
Free article
Abstract
Objective: Serrated polyposis syndrome (SPS) is accompanied by an increased risk of colorectal cancer (CRC). Patients fulfilling the clinical criteria, as defined by the WHO, have a wide variation in CRC risk. We aimed to assess risk factors for CRC in a large cohort of patients with SPS and to evaluate the risk of CRC during surveillance.
Design: In this retrospective cohort analysis, all patients with SPS from seven centres in the Netherlands and two in the UK were enrolled. WHO criteria were used to diagnose SPS. Patients who only fulfilled WHO criterion-2, with IBD and/or a known hereditary CRC syndrome were excluded.
Results: In total, 434 patients with SPS were included for analysis; 127 (29.3%) were diagnosed with CRC. In a per-patient analysis ≥1 serrated polyp (SP) with dysplasia (OR 2.07; 95% CI 1.28 to 3.33), ≥1 advanced adenoma (OR 2.30; 95% CI 1.47 to 3.67) and the fulfilment of both WHO criteria 1 and 3 (OR 1.60; 95% CI 1.04 to 2.51) were associated with CRC, while a history of smoking was inversely associated with CRC (OR 0.36; 95% CI 0.23 to 0.56). Overall, 260 patients underwent surveillance after clearing of all relevant lesions, during which two patients were diagnosed with CRC, corresponding to 1.9 events/1000 person-years surveillance (95% CI 0.3 to 6.4).
Conclusion: The presence of SPs containing dysplasia, advanced adenomas and/or combined WHO criteria 1 and 3 phenotype is associated with CRC in patients with SPS. Patients with a history of smoking show a lower risk of CRC, possibly due to a different pathogenesis of disease. The risk of developing CRC during surveillance is lower than previously reported in literature, which may reflect a more mature multicentre cohort with less selection bias.
Keywords: COLONIC POLYPS; COLONOSCOPY; COLORECTAL CANCER; POLYPOSIS; SURVEILLANCE.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Comment in
- Serrated polyposis syndrome: risk stratification or reduction?
Hassan C, Repici A, Rex DK. Hassan C, et al. Gut. 2016 Jul;65(7):1070-2. doi: 10.1136/gutjnl-2015-311357. Epub 2016 Feb 23. Gut. 2016. PMID: 26907826 No abstract available.
Similar articles
- Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study.
Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, López-Cerón M, Cuatrecasas M, López-Vicente J, Leoz ML, Rivero-Sánchez L, Castells A, Pellisé M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Carballal S, et al. Gut. 2016 Nov;65(11):1829-1837. doi: 10.1136/gutjnl-2015-309647. Epub 2015 Aug 11. Gut. 2016. PMID: 26264224 - High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome.
Rodríguez-Alcalde D, Carballal S, Moreira L, Hernández L, Rodríguez-Alonso L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, Saperas E, López-Cerón M, Cuatrecasas M, López-Vicente J, Rivero-Sánchez L, Jung G, Vila-Casadesús M, Sánchez A, Castells A, Pellisé M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Rodríguez-Alcalde D, et al. Endoscopy. 2019 Feb;51(2):142-151. doi: 10.1055/a-0656-5557. Epub 2018 Aug 1. Endoscopy. 2019. PMID: 30068004 - Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.
Egoavil C, Juárez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Piñol V, Rodríguez Moranta F, Nicolás-Pérez D, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Zapater P, Jover R. Egoavil C, et al. Gastroenterology. 2017 Jul;153(1):106-112.e2. doi: 10.1053/j.gastro.2017.04.003. Epub 2017 Apr 9. Gastroenterology. 2017. PMID: 28400194 - Risk factors for metachronous colorectal cancer or advanced lesions after endoscopic resection of serrated polyps: a systematic review and meta-analysis.
Baile-Maxía S, Mangas-Sanjuán C, Ladabaum U, Sánchez-Ardila C, Sala-Miquel N, Hassan C, Rutter MD, Bretthauer M, Zapater P, Jover R. Baile-Maxía S, et al. Gastrointest Endosc. 2024 Oct;100(4):605-615.e14. doi: 10.1016/j.gie.2024.05.021. Epub 2024 Jun 6. Gastrointest Endosc. 2024. PMID: 38851458 Review. - Serrated polyposis syndrome; epidemiology and management.
Carballal S, Balaguer F, IJspeert JEG. Carballal S, et al. Best Pract Res Clin Gastroenterol. 2022 Jun-Aug;58-59:101791. doi: 10.1016/j.bpg.2022.101791. Epub 2022 Mar 16. Best Pract Res Clin Gastroenterol. 2022. PMID: 35988960 Review.
Cited by
- Clinicopathological Correlates of Dysplastic Sessile Serrated Lesion: A Prospective Cohort Study With a High Detection Rate.
Lamba M, Brown I, Bettington M, Ryan K, Hanigan K, Lasenby K, Dixon A, Grimpen F, Gan C, Tutticci N, Appleyard M, Leggett B. Lamba M, et al. Gastro Hep Adv. 2022 Mar 30;1(3):313-320. doi: 10.1016/j.gastha.2021.12.010. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131677 Free PMC article. - Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
Chan JM, Clendenning M, Joseland S, Georgeson P, Mahmood K, Joo JE, Walker R, Como J, Preston S, Chai SM, Chu YL, Meyers AL, Pope BJ, Duggan D, Fink JL, Macrae FA, Rosty C, Winship IM, Jenkins MA, Buchanan DD. Chan JM, et al. Fam Cancer. 2024 Mar;23(1):9-21. doi: 10.1007/s10689-023-00351-2. Epub 2023 Dec 8. Fam Cancer. 2024. PMID: 38063999 Free PMC article. - Feasibility and Safety of Endoscopic Control for Patients with Serrated Polyposis Syndrome.
Nakaoka M, Chiba H, Kobayashi M, Okada N, Arimoto J, Tachikawa J, Ashikari K, Kuwabara H. Nakaoka M, et al. Dig Dis. 2024;42(1):31-40. doi: 10.1159/000534968. Epub 2023 Nov 15. Dig Dis. 2024. PMID: 37967542 Free PMC article. - The Progress of Colorectal Polyposis Syndrome in Chinese Population.
Yuan Z, Yang M, Yuan Y. Yuan Z, et al. Clin Colon Rectal Surg. 2023 Apr 9;36(6):391-399. doi: 10.1055/s-0043-1767708. eCollection 2023 Nov. Clin Colon Rectal Surg. 2023. PMID: 37795462 Free PMC article. Review. - What do 'false-positive' stool tests really mean? Data from the New Hampshire colonoscopy registry.
Butterly LF, Hisey WM, Robinson CM, Limburg PJ, Kneedler BL, Anderson JC. Butterly LF, et al. Prev Med Rep. 2023 Jul 3;35:102309. doi: 10.1016/j.pmedr.2023.102309. eCollection 2023 Oct. Prev Med Rep. 2023. PMID: 37449002 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical